Zobrazeno 1 - 10
of 570
pro vyhledávání: '"Christopher G, Morris"'
Autor:
Julie A. Bradley, MD, Xiaoying Liang, PhD, Raymond B. Mailhot Vega, MD, MPH, Chunbo Liu, PhD, Eric D. Brooks, MD, Teena Burchianti, ARNP, Emma Viviers, MS, Roi Dagan, MD, MS, Oluwadamilola T. Oladeru, MD, MA, MBA, Christopher G. Morris, MS, Nancy P. Mendenhall, MD
Publikováno v:
International Journal of Particle Therapy, Vol 9, Iss 4, Pp 269-278 (2023)
Purpose: To determine the rib fracture rate in a cohort of patients with breast cancer treated with proton therapy. Patient and Methods: From a prospective database, we identified 225 patients treated with proton therapy between 2012 and 2020 (223 wo
Externí odkaz:
https://doaj.org/article/d3e5fc85fd7c428aadf2996f42a03e7b
Autor:
Michael S. Rutenberg, MD, PhD, Bradford S. Hoppe, MD, MPH, Jason S. Starr, DO, Ziad Awad, MD, Mathew Thomas, MBBS, MD, Christopher G. Morris, MS, Perry Johnson, PhD, Randal H. Henderson, MD, MBA, Jeremy C. Jones, MD, Bharatsinh Gharia, MBBS, MD, Steven Bowers, MD, Herbert C. Wolfsen, MD, Sunil Krishnan, MBBS, MD, Stephen J. Ko, MD, Hani M. Babiker, MD, Romaine C. Nichols, Jr, MD
Publikováno v:
International Journal of Particle Therapy, Pp 18-29 (2022)
Purpose: When treating esophageal cancer with radiation therapy, it is critical to limit the dose to surrounding structures, such as the lung and/or heart, as much as possible. Proton radiation therapy allows a reduced radiation dose to both the hear
Externí odkaz:
https://doaj.org/article/6e0ce34c85cc410c8a3e146ab69d68ad
Autor:
Raymond B. Mailhot Vega, Beatriz E. Garcia Robles, Christopher G. Morris, Kara Buss, Ulises Mejia, Adela Poitevin, Maria Fatima Chilaca Rosas, Heynar Perez Villanueva, Jesus Armando Felix Leyva, Daniel J. Indelicato, Dolores De la Mata
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
PURPOSEMexico and Central America have the highest childhood cancer incidence in the West. Pediatric-specific oncology knowledge contributes to the disparity. We sought to (1) determine the self-identified treatment patterns and needs of Mexican pedi
Externí odkaz:
https://doaj.org/article/484ab3a2adbd4ef095751686658a183b
Handbook of Energy, Volume II: Chronologies, Top Ten Lists, and Word Clouds draws together a comprehensive account of the energy field from the prestigious and award-winning authors of the Encyclopedia of Energy (2004), The Dictionary of Energy, Expa
Autor:
Nancy P. Mendenhall, Sarah M. Rausch Osian, Curtis M. Bryant, Bradford S. Hoppe, Christopher G. Morris
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 6, Pp 2314-2326 (2021)
Abstract Data comparing outcomes in prostate cancer and factors affecting treatment choice are sparse. To inform the design of a comparative effectiveness clinical trial, we engaged patients in developing a 28‐question survey about decision making
Externí odkaz:
https://doaj.org/article/e601dda73bf44c2c8efdfb3f7a3a001a
Handbook of Energy, Volume I: Diagrams, Charts, and Tables provides comprehensive, organized coverage on all phases of energy and its role in society, including its social, economic, political, historical, and environmental aspects. While there is a
Autor:
James E. Bates, MD, Stephanie Terezakis, MD, Christopher G. Morris, MS, Avani D. Rao, MD, Shuchi Sehgal, BA, Rahul Kumar, MBBS, Raymond B. Mailhot Vega, MD, MPH, Nancy P. Mendenhall, MD, Bradford S. Hoppe, MD, MPH
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 3, Pp 21-27 (2021)
Purpose: Early stage (stages I-II) classical Hodgkin lymphoma (cHL) is a highly curable disease typically diagnosed in adolescents and young adults (AYAs). Proton therapy can also reduce the late toxicity burden in this population, but data on its co
Externí odkaz:
https://doaj.org/article/4662bd6f283b47d2addc8493de90f859
Autor:
Natalie A. Lockney, MD, Randal H. Henderson, MD, MBA, Steven G. Swarts, PhD, Zhenhuan Zhang, MD, PhD, Bingrong Zhang, DVM, MD, Jennifer Li, BS, Robert A. Zlotecki, MD, PhD, Christopher G. Morris, MS, Katherine A. Casey-Sawicki, MA, Paul G. Okunieff, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 3, Pp 28-35 (2021)
Background: After radiation therapy (RT), circulating plasma cell-free DNA (cfDNA) released in response to RT damage to tissue can be measured within hours. We examined for a correlation between cfDNA measured during the first week of therapy and ear
Externí odkaz:
https://doaj.org/article/6f789986096b4d19b2261b3f95ebd1cd
Autor:
William M. Mendenhall, MD, Eric D. Brooks, MD, MHS, Stephanie Smith, Christopher G. Morris, MS, Curtis B. Bryant, MD, MPH, Randal H. Henderson, MD, Romaine C. Nichols, Jr., MD, Kathy McIntyre, Stuart L. Klein, MHA, Nancy P. Mendenhall, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 3, Pp 36-42 (2021)
Purpose: To determine factors that influence insurance approval for definitive proton therapy (PT) for prostate cancer. Materials and Methods: Between 2014 and 2018, 1592 insured patients with localized prostate cancer were evaluated and recommended
Externí odkaz:
https://doaj.org/article/d56f508053b54ed0882190767981a28b
Autor:
Roi Dagan, MD, MS, Haruka Uezono, MD, Curtis Bryant, MD, Adam L. Holtzman, MD, Christopher G. Morris, MS, William M. Mendenhall, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 1, Pp 200-212 (2021)
Purpose: To report long-term disease control, survival, and toxicity after proton therapy for sinonasal cancer. Patients and Methods: We reviewed 143 cases of adults with nonmetastatic sinonasal cancers treated with primary (18%; n = 26) or adjuvant
Externí odkaz:
https://doaj.org/article/59928fbefea54bc899689b2377dcc556